These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2105098)

  • 1. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
    Luchins DJ; Dojka D
    Psychopharmacol Bull; 1989; 25(3):372-5. PubMed ID: 2626515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maladaptive behaviors associated with neuroleptic drug maintenance.
    Chadsey-Rusch J; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):607-17. PubMed ID: 2566315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral problems and medication utilization.
    Harper DC; Wadsworth JS
    Ment Retard; 1993 Apr; 31(2):97-103. PubMed ID: 8479337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
    Ruedrich SL; Grush L; Wilson J
    Am J Ment Retard; 1990 Jul; 95(1):110-9. PubMed ID: 1974768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects during lithium treatment for psychiatric disorders in adults with mental retardation.
    Pary R
    Am J Ment Retard; 1991 Nov; 96(3):269-73. PubMed ID: 1756031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse-provoking characteristics of institutionalized mentally retarded individuals.
    Rusch RG; Hall JC; Griffin HC
    Am J Ment Defic; 1986 May; 90(6):618-24. PubMed ID: 3717218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of psychotropic drugs on intelligence test performance of institutionalized mentally retarded adults.
    Breuning SE; Davidson NA
    Am J Ment Defic; 1981 May; 85(6):575-9. PubMed ID: 6791499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients.
    Barron J; Sandman CA
    Am J Ment Defic; 1983 Sep; 88(2):177-86. PubMed ID: 6638079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study.
    Verhoeven WM; Tuinier S
    J Intellect Disabil Res; 1996 Dec; 40 ( Pt 6)():502-8. PubMed ID: 9004110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response to antidepressant medications.
    Langee HR; Conlon M
    Am J Ment Retard; 1992 Jul; 97(1):65-70. PubMed ID: 1497865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of aggressivity and self-mutilation in the mentally retarded.
    Lapierre YD; Reesal R
    Psychiatr Clin North Am; 1986 Dec; 9(4):745-54. PubMed ID: 3543893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of mentally retarded patients with behavioral disorders who were treated with carbamazapine.
    Langee HR
    Am J Ment Retard; 1989 May; 93(6):640-3. PubMed ID: 2719847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social adjustment in more severely retarded, institutionalized individuals: the sum of adjusted behavior.
    Balthazar EE; Phillips JL
    Am J Ment Defic; 1976 Jan; 80(4):454-9. PubMed ID: 1247041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons.
    Glaser BA; Morreau LE
    Am J Ment Defic; 1986 Jan; 90(4):371-9. PubMed ID: 3946474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards defining adequate lithium trials for individuals with mental retardation and mental illness.
    Pary RJ
    Am J Ment Retard; 1991 May; 95(6):681-91. PubMed ID: 2059418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.